Project details
Israeli wound healing technology company seeks investment for market expansion.
| Project region | Israel |
|---|---|
| Industry | Biomedicine |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
| Project highlights | exclusive technology - CE certified - entering North America |
|---|---|
| Project description |
The Israeli company develops exclusive wound healing technology products, which promote wound healing by using synthetic negatively charged microspheres ("NCM") to stimulate cells involved in wound healing and tissue regeneration. The company's most advanced wound healing products are classified as IIb medical devices in Europe and are manufactured by factories with European Conformity ("CE") mark certification. The company's products are currently sold in the European Union and some Latin American countries, and it plans to enter the American and Canadian markets. Now the company seeks investment. |
We provide expert advisory and corporate services across Asia, guiding businesses through complex markets and regulations.
Have Any Questions?
Reach out to our local experts, we’ll respond within one business day.
Our Clients
Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.
See what our clients say about us
